This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Eticlopride
DrugBank Accession Number
DB15492
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 340.845
Monoisotopic: 340.155370383
Chemical Formula
C17H25ClN2O3
Synonyms
  • Eticloprida
  • Eticlopride
  • Eticlopridum

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
ApomorphineThe therapeutic efficacy of Apomorphine can be decreased when used in combination with Eticlopride.
AripiprazoleThe therapeutic efficacy of Aripiprazole can be decreased when used in combination with Eticlopride.
BenzatropineThe risk or severity of adverse effects can be increased when Eticlopride is combined with Benzatropine.
BrexpiprazoleThe therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Eticlopride.
BromocriptineThe therapeutic efficacy of Bromocriptine can be decreased when used in combination with Eticlopride.
CabergolineThe therapeutic efficacy of Cabergoline can be decreased when used in combination with Eticlopride.
DeutetrabenazineThe risk or severity of adverse effects can be increased when Eticlopride is combined with Deutetrabenazine.
DihydroergocornineThe therapeutic efficacy of Dihydroergocornine can be decreased when used in combination with Eticlopride.
DihydroergotamineThe therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Eticlopride.
DopexamineThe therapeutic efficacy of Dopexamine can be decreased when used in combination with Eticlopride.
Identify potential medication risks
Easily compare up to 40 drugs with our drug interaction checker.
Get severity rating, description, and management advice.
Learn more
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Eticlopride hydrochlorideHJ2CAH4TZ197612-24-3HFJFXXDHVWLIKX-YDALLXLXSA-N

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
J8M468HBH4
CAS number
84226-12-0
InChI Key
AADCDMQTJNYOSS-LBPRGKRZSA-N
InChI
InChI=1S/C17H25ClN2O3/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2/h9,12,21H,4-8,10H2,1-3H3,(H,19,22)/t12-/m0/s1
IUPAC Name
3-chloro-5-ethyl-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-6-hydroxy-2-methoxybenzamide
SMILES
CCN1CCC[C@H]1CNC(=O)C1=C(O)C(CC)=CC(Cl)=C1OC

References

General References
Not Available
ChemSpider
51626
BindingDB
50007518
ChEBI
92874
ChEMBL
CHEMBL8946
ZINC
ZINC000000001395
PDBe Ligand
ETQ
Wikipedia
Eticlopride
PDB Entries
3pbl

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.134 mg/mLALOGPS
logP3.05ALOGPS
logP2.85ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)7.86ChemAxon
pKa (Strongest Basic)8.68ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area61.8 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity92.9 m3·mol-1ChemAxon
Polarizability36.61 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at September 11, 2019 20:56 / Updated at February 21, 2021 18:55